192 related articles for article (PubMed ID: 26158530)
1. DNA vaccines 2014 meeting: Highlights and overview.
Ugen KE; Weiner DB
Hum Vaccin Immunother; 2015; 11(8):1887-8. PubMed ID: 26158530
[No Abstract] [Full Text] [Related]
2. DNA vaccines for biodefence.
Garmory HS; Perkins SD; Phillpotts RJ; Titball RW
Adv Drug Deliv Rev; 2005 Jun; 57(9):1343-61. PubMed ID: 15935877
[TBL] [Abstract][Full Text] [Related]
3. Letter from the Editor.
Ellis R; Weiss A
Hum Vaccin Immunother; 2015; 11(8):1883. PubMed ID: 26260960
[No Abstract] [Full Text] [Related]
4. Letter from the editor.
Ellis R; Riedmann EM
Hum Vaccin Immunother; 2013 Sep; 9(9):1825-6. PubMed ID: 24013451
[No Abstract] [Full Text] [Related]
5. Letter from the Editor.
Ellis R
Hum Vaccin Immunother; 2015; 11(10):2333. PubMed ID: 26376012
[No Abstract] [Full Text] [Related]
6. Letter from the editor.
Ellis R; Riedmann EM
Hum Vaccin Immunother; 2014; 10(1):1-2. PubMed ID: 24832715
[No Abstract] [Full Text] [Related]
7. Letter from the Editor.
Ellis R; Weiss A
Hum Vaccin Immunother; 2015; 11(6):1297. PubMed ID: 26086583
[No Abstract] [Full Text] [Related]
8. Toward the development of vectored vaccines in compliance with evolutionary medicine.
Tang DC; Van Kampen KR
Expert Rev Vaccines; 2008 May; 7(4):399-402. PubMed ID: 18444885
[No Abstract] [Full Text] [Related]
9. 3rd Global Vaccine Congress.
Kyd JM
Expert Rev Vaccines; 2010 Jan; 9(1):13-7. PubMed ID: 20021300
[TBL] [Abstract][Full Text] [Related]
10. DNA vaccines: a role for liposomes.
Gregoriadis G
Curr Opin Mol Ther; 1999 Feb; 1(1):39-42. PubMed ID: 11249682
[TBL] [Abstract][Full Text] [Related]
11. [Status and prospects of immunologic disease prevention].
Morunova AA
Pediatriia; 1989; (7):5-7. PubMed ID: 2780160
[No Abstract] [Full Text] [Related]
12. Overview of vaccines and vaccination.
Ada G
Mol Biotechnol; 2005 Mar; 29(3):255-72. PubMed ID: 15767703
[TBL] [Abstract][Full Text] [Related]
13. A focus on vaccination strategies.
Woodland DL
Viral Immunol; 2014 Nov; 27(9):421. PubMed ID: 25361209
[No Abstract] [Full Text] [Related]
14. Perspective: edible vaccines--a concept coming of age.
Mor TS; Gómez-Lim MA; Palmer KE
Trends Microbiol; 1998 Nov; 6(11):449-53. PubMed ID: 9846363
[TBL] [Abstract][Full Text] [Related]
15. Promotion of immunity of mice to Pasteurella multocida and hog cholera vaccine by pig interleukin-6 gene and CpG motifs.
Zhao ZZ; Zhang HB; Chen Q; Su D; Xie Z; Wang YY; Yang Y; Wang ZZ; Li JL; Wu KY; Wang HN; Meng MJ; Gao R
Comp Immunol Microbiol Infect Dis; 2009 May; 32(3):191-205. PubMed ID: 18279956
[TBL] [Abstract][Full Text] [Related]
16. [DNA vaccination--current status and future prospect--a new approach for controlling infectious diseases].
Sasaki S; Fukushima J; Okuda K
Nihon Saikingaku Zasshi; 1998 May; 53(2):407-24. PubMed ID: 9654941
[No Abstract] [Full Text] [Related]
17. Human immunodeficiency virus type 1 vaccine development: recent advances in the cytotoxic T-lymphocyte platform "spotty business".
Schoenly KA; Weiner DB
J Virol; 2008 Apr; 82(7):3166-80. PubMed ID: 17989174
[No Abstract] [Full Text] [Related]
18. [Clinical evaluation of new vaccines].
Eskola J; Kilpi T
Duodecim; 1996; 112(9):820-6. PubMed ID: 10592970
[No Abstract] [Full Text] [Related]
19. Recombinant vaccines.
Barnard RT
Expert Rev Vaccines; 2010 May; 9(5):461-3. PubMed ID: 20450319
[TBL] [Abstract][Full Text] [Related]
20. Attenuated salmonella and Shigella as carriers for DNA vaccines.
Xu F; Ulmer JB
J Drug Target; 2003; 11(8-10):481-8. PubMed ID: 15203916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
